Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
Public ClinicalTrials.gov record NCT02814643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, parallel group, placebo-controlled study designed to investigate the potential effect of a fixed dose of benralizumab administered subcutaneously (SC) on antibody responses following seasonal influenza virus vaccination
Study identification
- NCT ID
- NCT02814643
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 103 participants
Conditions and interventions
Conditions
Interventions
- Benralizumab Drug
- Benralizumab Placebo Drug
- Seasonal influenza virus vaccine Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2016 (Actual)
- Primary completion
- Jan 24, 2017 (Actual)
- Completion
- Jan 24, 2017 (Actual)
- Last update posted
- Oct 24, 2018
2016 – 2017
United States locations
- U.S. sites
- 24
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35209 | — |
| Research Site | Mesa | Arizona | 85206 | — |
| Research Site | Huntington Beach | California | 92647 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | Aurora | Colorado | 80012-4016 | — |
| Research Site | Colorado Springs | Colorado | 80907 | — |
| Research Site | Denver | Colorado | 80230 | — |
| Research Site | Aventura | Florida | 33180 | — |
| Research Site | Miami | Florida | 33135 | — |
| Research Site | Miami | Florida | 33173 | — |
| Research Site | Minneapolis | Minnesota | 55402 | — |
| Research Site | Bellevue | Nebraska | 68123 | — |
| Research Site | Northfield | New Jersey | 08225 | — |
| Research Site | Edmond | Oklahoma | 73034 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | North Charleston | South Carolina | 29420 | — |
| Research Site | Arlington | Texas | 76018 | — |
| Research Site | El Paso | Texas | 79903 | — |
| Research Site | New Braunfels | Texas | 78130 | — |
| Research Site | San Antonio | Texas | 78221 | — |
| Research Site | San Antonio | Texas | 78251 | — |
| Research Site | Waco | Texas | 76712 | — |
| Research Site | Clinton | Utah | 84015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02814643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 24, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02814643 live on ClinicalTrials.gov.